CVS subsidiary Omnicare Inc. has agreed to pay $15.3 million to settle claims brought by the U.S. Drug Enforcement Administration and federal prosecutors that it illegally dispensed opiate pharmaceuticals to long-term care facilities, such as assisted living and skilled nursing sites.
The settlement is among the most significant to involve a federal investigation into opioid distribution by a pharmacy, although the Department of Justice has charged individual pharmacies across the country.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
